Cancer-fighting T-cells, the immune system's primary enforcers, are scarce in the rare kidney cancer called chromophobe renal ...

The Korea Research Institute of Standards and Science has successfully developed a nanomaterial capable of simultaneously ...

Explore how the ratio of pd-1+ treg to ctl and the presence of tertiary lymphoid structures can influence treatment outcomes ...

Researchers use targeted lipid nanoparticles loaded with mRNA to reprogram T cells to fight autoimmune diseases ...

A team of researchers from the San Raffaele-Telethon Institute for Gene Therapy (SR-TIGET, Milan), led by Nadia Coltella and ...

Engineered chip mimics bone marrow and immune system, offering a faster, tailored path for cancer immunotherapy.

Treating types of cancer with CAR T-cell therapy is expensive and inconvenient, but a streamlined approach that creates the ...

A team of researchers from the San Raffaele-Telethon Institute for Gene Therapy (SR-TIGET, Milan), led by Nadia Coltella and ...

Gynecologic clear cell cancers are aggressive malignant neoplasms with low response rates to chemotherapy. Among patients ...

In recent years, cancer treatment has taken a big leap forward with a new, advancement known as CAR T-cell therapy. This may ...

With immunotherapy increasingly making it out of the lab and into hospitals as a viable way to treat serious conditions like ...

CAR T-cell therapy may cure up to 40% of patients with lymphoma and is an option for those who can’t receive transplants, ...